UBS Global Research on Tuesday raised its year-end target for the benchmark S&P 500 index to 5,850 points from an earlier ...

AbbVie has been reporting an earnings decline because its former lead drug, Humira, lost patent-protected market exclusivity ...

One chief equity strategist says that the S&P 500 Index could face a significant decline next year following its 2024 gains.

The S&P 500 advanced 0.8% on Monday, adding to the benchmark index's all-time high Friday for a second straight record close.

MicroStrategy stock has outperformed all S&P 500 firms since 2020, but despite its robust performance, a listing in the index ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

The S&P 500 index was up slightly Wednesday, with sector gains led by utilities and financials, according to FactSet data, at last check. The utilities sector was up 1.1% Wednesday morning, while the ...

The S&P 500 and Nasdaq rose on Monday, with the benchmark index touching an intraday record high as investors geared up for a ...

S&P 500 futures are up 0.1%. Dow Jones Industrial Average futures are down 0.1%. Nasdaq 100 futures are adding 0.2%. On Tuesday, the Dow Jones Industrial Average fell 325 points, or 0.75%, to 42,740, ...

Short interest for healthcare stocks in S&P 500 increased during September end vs. last month, with Moderna being most ...

The S&P 500 may be punching through fresh records, but it hasn’t been accompanied by high turnover conviction. On the ...

The S&P 500 finished the week ending October 11 with another record-breaking rally, up 0.97% from last Friday.